Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04428203
Title Epidiolex (CBD) in Patients With Biochemically Recurrent Prostate Cancer
Recruitment Completed
Gender male
Phase Phase I
Variant Requirements No
Sponsors Zin W Myint
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Markey Cancer Center Lexington Kentucky 40536 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field